Live feed07:38:44·1818dPRReleasevia QuantisnowAlector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseasesByQuantisnow·Wall Street's wire, on your screen.GSK· GSK plcALEC· Alector Inc.Health Care